Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2021 at "CNS Drugs"
DOI: 10.1007/s40263-021-00843-8
Abstract: Anti-CD20 therapies have demonstrated considerable efficacy in the treatment of relapsing multiple sclerosis, constituting a high-efficacy treatment approach for reducing relapse risk and mitigating disability progression. These therapies have been shown to strongly deplete circulating… read more here.
Keywords: pharmacological attributes; multiple sclerosis; cd20 therapies; anti cd20 ... See more keywords
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
Sign Up to like & getrecommendations! Published in 2022 at "Practical Neurology"
DOI: 10.1136/pn-2022-003426
Abstract: Neurologists increasingly use anti-CD20 therapies, including for women of childbearing age, despite these medications being unlicensed for use in pregnancy. Current evidence suggests that women can safely conceive while taking anti-CD20 therapy. Women should not… read more here.
Keywords: breast feeding; therapies pregnancy; anti cd20; pregnancy ... See more keywords
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1004795
Abstract: The immune system plays a significant role in multiple sclerosis. While MS was historically thought to be T cell-mediated, multiple pieces of evidence now support the view that B cells are essential players in multiple… read more here.
Keywords: pathology; cd20 therapies; multiple sclerosis; anti cd20 ... See more keywords